BioGenex Takes Over Support for Xmatrx Platform Following End of Abbott Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – BioGenex and Abbott Molecular today announced that BioGenex will take over direct sales and support responsibility for the co-branded Xmatrx instruments, auto FISH reagents, and consumables.

The two firms had a "long and successful collaboration and partnership," said BioGenex, centered on BioGenex's Xmatrx platform, and in 2009 extended an assay deal to market the Xmatrx platform for the automation of Abbott's FISH product line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.